Gender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National Registry of Urinary Bladder Cancer

Scandinavian Journal of Urology

Volumn 50, Issue 4, 2016, Pages 292-297

  Thorstenson, Andreas ^a,b   Hagberg, Oskar ^c   Ljungberg, Börje ^d   Liedberg, Fredrik ^c   Jancke, Georg ^e   Holmäng, Sten ^f   Malmström, Per Uno ^g   Hosseini, Abolfazl ^a   Jahnson, Staffan ^e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

^e LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bladder cancer; female; gender; male; population based; survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; AGED; ARTICLE; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; SEX DIFFERENCE; SWEDEN; TRANSITIONAL CELL CARCINOMA; CARCINOMA, TRANSITIONAL CELL; COMPARATIVE STUDY; MORTALITY; PATHOLOGY; REGISTER; SURVIVAL RATE; URINARY BLADDER NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; MALE; REGISTRIES; SEX FACTORS; SURVIVAL RATE; SWEDEN; URINARY BLADDER NEOPLASMS;

EID: 84961391574     PISSN: 21681805     EISSN: 21681813     Source Type: Journal    
DOI: 10.3109/21681805.2016.1158207     Document Type: Article

References (30)

1. S.Jahnson, O.Damm, S.Hellsten, S.Holmang, F.Liedberg, B.Ljungberg,. A population-based study of patterns of care for muscle-invasive bladder cancer in Sweden. Scand J Urol Nephrol 2009;43:271–6.
2. N.A.Mungan, K.K.Aben, M.P.Schoenberg, O.Visser, J.W.Coebergh, J.A.Witjes,. Gender differences in stage-adjusted bladder cancer survival. Urology 2000;55:876–80.
3. P.U.Malmstrom, M.Thorn, P.Lindblad, R.Bergstrom, H.O.Adami Increasing survival of patients with urinary bladder cancer. A nationwide study in Sweden 1960-1986. Eur J Cancer 1993;29A:1868–72.
4. T.Waldhoer, I.Berger, G.Haidinger, N.Zielonke, S.Madersbacher Sex differences of ≥ pT1 bladder cancer survival in Austria: a descriptive, long-term, nationwide analysis based on 27,773 patients. Urol Int 2015;94:383–9.
5. J.F.Ludvigsson, P.Otterblad-Olausson, B.U.Pettersson, A.Ekbom The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009;24:659–67.
6. TNM classification of malignant tumours, Fourth Edition. Editors: P.Hermanek and L.H.Sobin. Springer-Verlag, Berlin, 1987.
7. TNM classification of malignant tumours, Fifth Edition. Editors: L.H.Sobin and C.WittekindCh. Wiley-Liss, Inc., New York, 1997.
8. TNM classification of malignant tumours, Sixth Edition. Editors: L.H.Sobin and C.WittekindCh. Wiley-Liss, Inc., New York, 2004.
9. TNM classification of malignant tumours, Seventh Edition. Editors: L.H.Sobin and C.WittekindCh. Wiley-Liss, Inc., New York, 2009.
10. F.K.Mostofi, L.H.Sobin, H.Torloni Histopathological typing of urinary bladder tumours. International histological classification of tumours No 19. Geneva: World Health Organization; 1973.
11. I.Epstein, M.B.Amin, V.R.Reuter, F.K.Mostofi The World Health Organization/International Society of Urological Pathology Consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435–48.
12. M.Pohar, J.Stare Making relative survival analysis relatively easy. Comput Biol Med 2007;37:1741–9.
13. RCoreTeam. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2013.
14. A.P.Noon, P.C.Albertsen, F.Thomas, D.J.Rosario, J.W.Catto Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients. Br J Cancer 2013;108:1534–40.
15. H.Donsky, S.Coyle, E.Scosyrev, E.M.Messing Sex differences in incidence and mortality of bladder and kidney cancers: national estimates from 49 countries. Urol Oncol 2014;32:23–31.
16. S.F.Shariat, J.P.Sfakianos, M.J.Droller, P.I.Karakiewicz, S.Meryn, B.H.Bochner The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int 2010;105:300–8.
17. L.A.Kluth, H.Fajkovic, E.Xylinas, J.J.Crivelli, N.Passoni, M.Roupret,. Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder. World J Urol 2013;31:1029–36.
18. K.Chamie, M.S.Litwin, J.C.Bassett, T.J.Daskivich, J.Lai, J.M.Hanley,. Recurrence of high-risk bladder cancer: a population-based analysis. Cancer 2013;119:3219–27.
19. T.Gardmark, A.Bladstrom, S.Hellsten, P.U.Malmstrom, Members of the Swedish National Bladder Cancer Registry. Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001. Scand J Urol 2006;40:276–82.
20. L.A.Kluth, M.Rieken, E.Xylinas, M.Kent, M.Rink, M.Roupret,. Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. Eur Urol 2014;66:913–19.
21. W.Otto, M.May, H.M.Fritsche, D.Dragun, A.Aziz, M.Gierth,. Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gender Med 2012;9:481–9.
22. D.Puente, N.Malats, L.Cecchini, A.Tardon, R.Garcia-Closas, C.Serra,. Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer. Eur Urol 2003;43:53–62.
23. R.T.Bryan, M.P.Zeegers, E.H.van Roekel, D.Bird, M.R.Grant, J.A.Dunn,. A comparison of patient and tumour characteristics in two UK bladder cancer cohorts separated by 20 years. BJU Int 2013;112:169–75.
24. N.E.Fleshner, H.W.Herr, A.K.Stewart, G.P.Murphy, C.Mettlin, H.R.Menck The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1996;78:1505–13.
25. A.Soave, R.Dahlem, J.Hansen, L.Weisbach, S.Minner, O.Engel,. Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort. Eur J Surg Oncol 2015;41:368–77.
26. R.B.Walter, T.M.Brasky, S.A.Buckley, J.D.Potter, E.White Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst 2013;105:860–8.
27. T.Garg, L.C.Pinheiro, C.L.Atoria, S.M.Donat, J.S.Weissman, H.W.Herr,. Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis. J Urol 2014;192:1072–7.
28. G.Lyratzopoulos, G.A.Abel, S.McPhail, R.D.Neal, G.P.Rubin Gender inequalities in the promptness of diagnosis of bladder and renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey. BMJ Open 2013;3:e002861.
29. E.K.Johnson, S.Daignault, Y.Zhang, C.T.Lee Patterns of hematuria referral to urologists: does a gender disparity exist? Urology 2008;72:498–502.
30. J.A.Cohn, B.Vekhter, C.Lyttle, G.D.Steinberg, M.C.Large Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation. Cancer 2014;120:555–61.